Back

Prevalence and prognostic value of significant mitral regurgitation development after pacemaker implantation

25 August 2023 (09:15 - 09:55)
Organised by: Logo
Congress Presentation Part of: Mechanisms and outcomes in valvular heart disease Mitral Valve Regurgitation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Takeru Nabeta

Kitasato University School of Medicine, Sagamihara (Japan)

7 More presentations in this session

Presentation thumbnail
Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes
Doctor S. Ratwatte (London, GB)
Abstract Slides Video
Presentation thumbnail
Association of aortic valve size with the degree of aortic valve calcification in patients with severe aortic stenosis
Miss R. Mousavi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Sex influence in the etiology and long-term prognosis of significant tricuspid regurgitation
Doctor G. Alegre Garcia (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Mitral annular calcification in patients with severe aortic stenosis underwent transcatheter aortic valve implantation: prevalence and association with stenosis severity
Miss A. Wicheantawatchai (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Arrhythmic form of mitral valve prolapse: presentation, risk stratification and management
Doctor Y. Elgharably (Cairo, EG)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms and outcomes in valvular heart disease

The Event

Event poster

ESC Congress 2023

25 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of tricuspid regurgitation in leadless pacemaker implantation
thumbnail
Congress Presentation
Prognostic significance of functional mitral regurgitation in heart failure patients undergoing cardiac resynchronization therapy
thumbnail
Congress Presentation
The effects of surgical and transcatheter aortic valve replacement for aortic stenosis on regression and progression of mitral regurgitation -a propensity score matched analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources